Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Risk Factors for the Development of High-Titer Inhibitors in 260 Children with Severe Hemophilia a Born Between 1990 and 2009: The Remain Study

Blood (2016) 128 (22): 3774.

https://doi.org/10.1182/blood.V128.22.3774.3774

Published: 2016

Journal Articles

Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia

Mark T. S. Williams, Yasar Yousafzai, Charlotte Cox, Allison Blair, Ruaidhrí Carmody, Shuji Sai, Karen E. Chapman, Rachel McAndrew, Angela Thomas, Alison Spence, Brenda Gibson, Gerard J. Graham, Christina Halsey

Blood (2014) 123 (20): 3116–3127.

https://doi.org/10.1182/blood-2013-05-499970

Published: 2014

Includes: Supplemental data

Journal Articles

GATA1 -mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia

Blood (2013) 122 (24): 3908–3917.

https://doi.org/10.1182/blood-2013-07-515148

Published: 2013

Includes: Supplemental data

Journal Articles

Familial AML With Germline CEBPA Mutations: Extended Clinical Outcomes and Analysis Of Secondary Mutations Using Whole Exome Sequencing

Kiran Tawana, MD, Aline Renneville, Jun Wang, PhD, Panayiotis Georgiades, Xavier Thomas, MD, Valerie Mialou, MD, Aleksander Savic, MD, Frederik W Van Delft, MD PhD, Jennifer G. Treleaven, MD, Sameena Iqbal, Norio Asou, MD, PhD, Naokuni Uike, MD, Konstanze Döhner, MD, Lars Bullinger, MD, PhD, Matthias Stelljes, MD, Csaba Bödör, PhD, James D. Cavenagh, MD, Doris Steinemann, PhD, Tim Ripperger, MD, Brigitte Schlegelberger, MD, PhD, Peter Vandenberghe, MD, PhD, Anne Uyttebroeck, MD, Josep F. Nomdedeu, MD, Henrik Hjorth-Hansen, MD, PhD, Rosemary E Gale, PhD, Cynthia L. Toze, MD, FRCP(C), Michael J. Barnett, BMBS, FRCPC, FRCP, FRCPath, Marianna Zombori, MD, Krisztian Kallay, MD, Jiri Pavlu, MD, Pim Mutsaers, MD, Fred H Menko, MD, Angela Thomas, PhD, FRCPath, FRCP, MB, BS, Christine Wright, MD, Jessica Okosun, MD, Chey Loveday, PhD, Pierre Fenaux, MD, PhD, Hamish Scott, PhD, Claude Preudhomme, Claude Chelala, PhD, Alison Male, MD, Carolyn J. Owen, MD, FRCPC, Matthew Smith, MD, PhD, Jude Fitzgibbon, PhD

Blood (2013) 122 (21): 740.

https://doi.org/10.1182/blood.V122.21.740.740

Published: 2013

Journal Articles

Cytoskeletons of X-Linked GATA-1, G208S Macrothrombocytes Are Deficient in Talin.

James G. White, MD, Steven M. Burris, Angela Thomas, M.B., M.S., Ph.D., FRCPE, FRCPCH

Blood (2008) 112 (11): 1829.

https://doi.org/10.1182/blood.V112.11.1829.1829

Published: 2008

Journal Articles

Selective impairment of platelet activation to collagen in the absence of GATA1

Sascha C. Hughan, Yotis Senis, Denise Best, Angela Thomas, Jon Frampton, Paresh Vyas, Steve P. Watson

Blood (2005) 105 (11): 4369–4376.

https://doi.org/10.1182/blood-2004-10-4098

Published: 2005

Journal Articles

Natural history of GATA1 mutations in Down syndrome

Momin Ahmed, Alexander Sternberg, Georgina Hall, Angela Thomas, Owen Smith, Aengus O'Marcaigh, Robert Wynn, Richard Stevens, Michael Addison, Derek King, Barbara Stewart, Brenda Gibson, Irene Roberts, Paresh Vyas

Blood (2004) 103 (7): 2480–2489.

https://doi.org/10.1182/blood-2003-10-3383

Published: 2004

NARROW

Risk Factors for the Development of High-Titer Inhibitors in 260 Children with Severe Hemophilia a Born Between 1990 and 2009: The Remain Study

Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia

GATA1 -mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia

Familial AML With Germline CEBPA Mutations: Extended Clinical Outcomes and Analysis Of Secondary Mutations Using Whole Exome Sequencing

Cytoskeletons of X-Linked GATA-1, G208S Macrothrombocytes Are Deficient in Talin.

Selective impairment of platelet activation to collagen in the absence of GATA1

Natural history of GATA1 mutations in Down syndrome

Email alerts

ASH Publications

American Society of Hematology

Risk Factors for the Development of High-Titer Inhibitors in 260 Children with Severe Hemophilia a Born Between 1990 and 2009: The Remain Study

Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia

GATA1 -mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia

Familial AML With Germline CEBPA Mutations: Extended Clinical Outcomes and Analysis Of Secondary Mutations Using Whole Exome Sequencing

Cytoskeletons of X-Linked GATA-1, G208S Macrothrombocytes Are Deficient in Talin.

Selective impairment of platelet activation to collagen in the absence of GATA1

Natural history of GATA1 mutations in Down syndrome

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only